To Normoglycemia and Beyond: Updates in Diabetes Therapy | Elizabeth Bald, PharmD, BCACP and Hanna Raber, PharmD

Dr. Elizabeth Bald and Dr. Hanna Raber

Dr. Elizabeth Bald works as an Assistant Professor (Clinical) at the University of Utah College of Pharmacy. She practices as a clinical pharmacist at the Madsen Family Medicine Clinic and uses collaborative practice agreements to manage a variety of disease states including diabetes, hypertension, asthma, smoking cessation, and osteoporosis. Dr. Bald received her PharmD from Drake University in Des Moines, Iowa. She completed a PGY-1 Pharmacy Practice residency and a PGY-2 Ambulatory Care Residency at the University of Iowa Hospitals and Clinics in Iowa City, Iowa. 

Dr. Hanna Raber is originally from Iowa and completed her PharmD from Drake University in Des Moines, Iowa. After graduation, she completed two years of residency in ambulatory care pharmacy within a family medicine residency program at Saint Joseph Regional Medical Center in Mishawaka, Indiana. Her practice interests include chronic disease management, team-based care, and health behavior change. Dr. Raber is currently an assistant clinical professor at the University of Utah College of Pharmacy and a clinical pharmacist at Madsen Family Medicine Clinic.

Learning Objectives:

1. Compare and contrast the benefits of SGLT2 inhibitors and GLP-1 agonists as add-on therapies for the treatment of type 2 diabetes mellitus (T2DM)

2. Review available higher concentration insulin products and determine which patients may benefit from use of higher concentration insulin

3. Identify patients with T2DM that would benefit from personal continuous glucose monitoring (P-CGM) and those that are most likely to be eligible for insurance coverage of P-CGM

4. Utilize P-CGM data to make treatment modifications for patients with T2DM

Presentation Materials: